In this issue (10 articles)

1. 

   Clinical Trials Report

   Antilymphoma therapy with a Bcl-6 inhibitor

   Peter McLaughlin Pages 183-184

   Get Access

2. 

   Clinical Trials Report

   Chemoimmunotherapy with modified dosing of fludarabine, cyclophosphamide, and rituximab shows significant clinical activity in patients with previously untreated chronic lymphocytic leukemia

   Nicole Lamanna, Mark A. Weiss Pages 185-186

   Get Access

3. 

   OriginalPaper

   Vaccination strategies in follicular lymphoma

   Shibichakravarthy Kannan, Sattva S. Neelapu Pages 189-195

   Look Inside Get Access

4. 

   OriginalPaper

   The host-tumor interface in B-cell non-Hodgkin lymphoma: A new world to investigate

   Nicolas Rachinel, Gilles Salles Pages 196-201

   Look Inside Get Access

5. 

   OriginalPaper

   Prognostic factors in low-grade non-Hodgkin lymphomas

   Massimo Federico, Stefano Molica, Monica Bellei… Pages 202-210

   Look Inside Get Access

6. 

   OriginalPaper

   Frontline therapy in mantle cell lymphoma: The role of high-dose therapy and integration of new agents

   Brad S. Kahl Pages 213-217

   Look Inside Get Access

7. 

   OriginalPaper

   Beyond R-CHOP and the IPI in large-cell lymphoma: Molecular markers as an opportunity for stratification

   Jason R. Westin, Luis E. Fayad Pages 218-224

   Look Inside Get Access

8. 

   OriginalPaper

   Update on the World Health Organization classification of peripheral T-cell lymphomas

   Hilary M. O’Leary, Kerry J. Savage Pages 227-235

   Look Inside Get Access

9. 

   OriginalPaper

   Hemopoietic stem cell transplantation in T-cell malignancies: Who, when, and how?

   Francesco d’Amore, Esa Jantunen, Thomas Relander Pages 236-244

   Look Inside Get Access

10. 

    OriginalPaper

    Natural killer-cell neoplasms

    John P. Greer, Claudio A. Mosse Pages 245-252

    Look Inside Get Access